Atıf İçin Kopyala
Dincol D., Arican A., Aydin F., Samur M., Willke A., AKBULUT H., ...Daha Fazla
CANCER JOURNAL - FRANCE, cilt.11, sa.2, ss.89-93, 1998 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
11
Sayı:
2
-
Basım Tarihi:
1998
-
Dergi Adı:
CANCER JOURNAL - FRANCE
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.89-93
-
Anahtar Kelimeler:
febrile neutropenia, imipenem, cefoperazone, sulbactam, amikacin, RANDOMIZED TRIAL, CEFTAZIDIME, FEVER, THERAPY, PIPERACILLIN, MANAGEMENT, TOBRAMYCIN, GENTAMICIN
-
Ankara Üniversitesi Adresli:
Hayır
Özet
Background - Empirical antibiotic therapy with a third-generation cephalosporin or a beta-lactam antibiotic which has broad antibacterial spectrum has been standard treatment in cancer patients with neutropenic fever. This prospective randomized trial was carried out to compare the efficacy of monotherapy (imipenem) with combination therapy (cefoperazone/sulbactam plus amikacin) in the empirical treatment of febrile neutropenia,